- Home
- CAPT vs AEON Comparison
CAPT vs AEON Comparison
Compare CAPT & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPT
- AEON
- Stock Information
- Founded
- CAPT 2005
- AEON N/A
- Country
- CAPT South Korea
- AEON United States
- Employees
- CAPT N/A
- AEON N/A
- Industry
- CAPT Blank Checks
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- CAPT Finance
- AEON Health Care
- Exchange
- CAPT Nasdaq
- AEON Nasdaq
- Market Cap
- CAPT 41.9M
- AEON 36.4M
- IPO Year
- CAPT N/A
- AEON N/A
- Fundamental
- Price
- CAPT $0.68
- AEON $0.63
- Analyst Decision
- CAPT
- AEON Strong Buy
- Analyst Count
- CAPT 0
- AEON 1
- Target Price
- CAPT N/A
- AEON $5.00
- AVG Volume (30 Days)
- CAPT 334.4K
- AEON 287.2K
- Earning Date
- CAPT 01-01-0001
- AEON 11-13-2024
- Dividend Yield
- CAPT N/A
- AEON N/A
- EPS Growth
- CAPT N/A
- AEON N/A
- EPS
- CAPT N/A
- AEON 0.34
- Revenue
- CAPT $17,389,944.00
- AEON N/A
- Revenue This Year
- CAPT N/A
- AEON N/A
- Revenue Next Year
- CAPT N/A
- AEON N/A
- P/E Ratio
- CAPT N/A
- AEON $1.79
- Revenue Growth
- CAPT 84.70
- AEON N/A
- 52 Week Low
- CAPT $0.65
- AEON $0.52
- 52 Week High
- CAPT $7.92
- AEON $17.17
- Technical
- Relative Strength Index (RSI)
- CAPT 36.38
- AEON 47.82
- Support Level
- CAPT $0.65
- AEON $0.61
- Resistance Level
- CAPT $0.99
- AEON $0.85
- Average True Range (ATR)
- CAPT 0.11
- AEON 0.11
- MACD
- CAPT 0.01
- AEON 0.02
- Stochastic Oscillator
- CAPT 8.70
- AEON 33.28
About CAPT Captivision Inc.
Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.